Predict your next investment

Incubator/Accelerator
INDUSTRIALS
ilabaccelerator.com

See what CB Insights has to offer

Investments

15

About i.lab

ilab provides a supportive environment for University of Queensland entrepreneurs. such as students, researchers and alumni. by mentoring them through the early stage of business development and providing seed funding to scale their business.

i.lab Headquarter Location

Building 20, ground floor, Global Change Institute (GCI) Staff House Road The University of Queensland

St Lucia, Queensland, 4070,

Australia

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest i.lab News

Virginia Bio Elects New Officers for Board of Directors

Aug 29, 2017

August 29, 2017 04:06 PM Eastern Daylight Time RICHMOND, Va.--( BUSINESS WIRE )--Virginia Bio, the premier statewide non-profit association of the life science industry in Virginia, elected Andrew J. Krouse to a two-year term as Chairman of the Board of Directors, during the annual meeting of the Board held at i.Lab at UVA . Andrew Krouse, MALS, is the President & CEO of Cavion, Inc. , a venture-backed pharmaceutical company in Charlottesville, developing best-in-class T-type calcium channel (Cav3) therapies that restore the brain’s natural rhythms and normal function in diseases that share a common pathophysiology, including movement disorders, epilepsy, and pain. Mr. Krouse has over a decade of biotech leadership experience as founder of Tau Therapeutics LLC, Xdynia LLC and Cavion, Inc. Mr. Krouse has served as a member of the Virginia Bio Board of Directors since 2011, most recently as Vice-Chairman. “I look forward to working with my colleagues throughout industry and academia to keep this great organization going strong," said Mr. Krouse. “My priorities will be to increase access of Virginia companies to private investment, engender a richer active engagement of all of our members in our community, and better communicate the story of Virginia bioscience commercialization to policy makers and other stakeholders.” Alan Connor, President & CEO of Cadence Inc. , Staunton, was elected as Vice-Chairman. Cadence Inc. is a full-service contract manufacturer and leading supplier of advanced products, technologies and services to medical device, life science, and industrial companies worldwide. Ross Dunlap, CEO and a co-founder of Ceres Nanosciences , Prince William County, was elected Secretary. Among other things, Mr. Dunlap is directing the clinical development, validation, and market launch of a novel Lyme Antigen Test that will provide the most sensitive and accurate detection of Lyme disease. The board also elected as a new Director Eric Paradise, who is a Senior Director in business development at MedImmune , the global biologics R&D arm of AstraZeneca. Other officers and members of the Executive Committee of Virginia Bio Board are Crystal Icenhour, CEO Aperiomics , Ashburn, Immediate Past Chair; Jeff Conroy, CEO Embody LLC , Norfolk, Past Chair; Carrie Roth, CEO VA Bio+Tech Park , Richmond, Treasurer; and Jim Powers, CEO HemoShear , Charlottesville. The complete list of Virginia Bio board members is at http://www.vabio.org/?leadership . About Virginia Bio Virginia Bio is the premier statewide non-profit trade association for life sciences, promoting the considerable scientific and economic impact of the life sciences industry in the Commonwealth of Virginia. Virginia Bio is an advocate for innovation and entrepreneurship, and for the biopharmaceutical, and other health technology industries among federal, state and local policy-makers. Virginia Bio is the official state affiliate of BIO (the Biotechnology Innovation Organization), AdvaMed and MDMA (Medical Device Manufacturers Association), and works closely with PhRMA (Pharmaceutical Research and Manufacturers of America). To learn more, visit www.vabio.org or follow Virginia Bio on Twitter at @VABio Contacts

i.lab Investments

15 Investments

i.lab has made 15 investments. Their latest investment was in Rise 4 REAL Change as part of their Incubator/Accelerator on June 6, 2017.

CBI Logo

i.lab Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/13/2017

Incubator/Accelerator

Rise 4 REAL Change

Yes

1

11/17/2016

Seed

Veilability

Yes

Incubator/Accelerator

Fedelta

Yes

Incubator/Accelerator

Subscribe to see more

Subscribe to see more

0

Incubator/Accelerator

Subscribe to see more

Subscribe to see more

0

Date

6/13/2017

11/17/2016

Round

Incubator/Accelerator

Seed

Incubator/Accelerator

Incubator/Accelerator

Incubator/Accelerator

Company

Rise 4 REAL Change

Veilability

Fedelta

Subscribe to see more

Subscribe to see more

Amount

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

0

0

i.lab Team

1 Team Member

i.lab has 1 team member, including former Chief Executive Officer, Anne Marie Birkill.

Name

Work History

Title

Status

Anne Marie Birkill

Chief Executive Officer

Former

Name

Anne Marie Birkill

Work History

Title

Chief Executive Officer

Status

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.